NO20030795L - Kinazolinderivater - Google Patents

Kinazolinderivater

Info

Publication number: NO20030795L
Authority: NO; Norway
Prior art keywords: quinazoline
Prior art date: 2000-08-21

Application number

NO20030795A

Other languages

English (en)

Other versions

NO326515B1 (no

NO20030795D0 (no

Inventor

Laurent Francois And Hennequin

Patrick Ple

Christine Marie Paul Lambert

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-21

Filing date

2003-02-20

Publication date

2003-04-04

2003-02-20 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2003-02-20 Publication of NO20030795D0 publication Critical patent/NO20030795D0/no

2003-04-04 Publication of NO20030795L publication Critical patent/NO20030795L/no

2008-12-22 Publication of NO326515B1 publication Critical patent/NO326515B1/no

Links

JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO20030795A 2000-08-21 2003-02-20 Kinazolinderivater, anvendelse og fremstilling derav, samt farmasoytisk preparat NO326515B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP00402320		2000-08-21
EP01401006		2001-04-19
PCT/GB2001/003649 WO2002016352A1 (en)	2000-08-21	2001-08-15	Quinazoline derivatives

Publications (3)

Publication Number	Publication Date
NO20030795D0 NO20030795D0 (no)	2003-02-20
NO20030795L true NO20030795L (no)	2003-04-04
NO326515B1 NO326515B1 (no)	2008-12-22

Family

ID=26073540

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030795A NO326515B1 (no)	2000-08-21	2003-02-20	Kinazolinderivater, anvendelse og fremstilling derav, samt farmasoytisk preparat

Country Status (21)

Country	Link
US (1)	US7115615B2 (no)
EP (1)	EP1313727A1 (no)
JP (1)	JP2004506732A (no)
KR (2)	KR20080027400A (no)
CN (1)	CN100347169C (no)
AR (1)	AR033560A1 (no)
AU (2)	AU7860901A (no)
BR (1)	BR0113358A (no)
CA (1)	CA2419301C (no)
CZ (1)	CZ2003486A3 (no)
EE (1)	EE05387B1 (no)
IL (2)	IL154131A0 (no)
MX (1)	MXPA03001332A (no)
MY (1)	MY129809A (no)
NO (1)	NO326515B1 (no)
NZ (1)	NZ523702A (no)
PL (1)	PL202812B1 (no)
RU (1)	RU2267489C2 (no)
SK (1)	SK2142003A3 (no)
TW (1)	TWI280960B (no)
WO (1)	WO2002016352A1 (no)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA73993C2 (uk)	2000-06-06	2005-10-17	Астразенека Аб	Хіназолінові похідні для лікування пухлин та фармацевтична композиція
JP2004511479A (ja)	2000-10-13	2004-04-15	アストラゼネカ　アクチボラグ	キナゾリン誘導体
AU2001292137A1 (en)	2000-10-13	2002-04-22	Astrazeneca Ab	Quinazoline derivatives
JP4564713B2 (ja)	2000-11-01	2010-10-20	ミレニアム・ファーマシューティカルズ・インコーポレイテッド	窒素性複素環式化合物、ならびに窒素性複素環式化合物およびその中間体を作製するための方法
JP4307843B2 (ja) *	2001-04-19	2009-08-05	アストラゼネカアクチボラグ	キナゾリン誘導体
WO2003008409A1 (en)	2001-07-16	2003-01-30	Astrazeneca Ab	Quinoline derivatives and their use as tyrosine kinase inhibitors
GB0128109D0 (en) *	2001-11-23	2002-01-16	Astrazeneca Ab	Therapeutic use
AU2002365664A1 (en) *	2001-12-05	2003-06-17	Astrazeneca Ab	Quinoline derivatives as antitumour agents
SI1474420T1 (sl) *	2002-02-01	2012-06-29	Astrazeneca Ab	Spojine kinazolina
TWI324597B (en) *	2002-03-28	2010-05-11	Astrazeneca Ab	Quinazoline derivatives
US6924285B2 (en)	2002-03-30	2005-08-02	Boehringer Ingelheim Pharma Gmbh & Co.	Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
GB0215823D0 (en)	2002-07-09	2002-08-14	Astrazeneca Ab	Quinazoline derivatives
EP1528925B1 (en) *	2002-07-09	2009-04-22	Astrazeneca AB	Quinazoline derivatives for use in the treatment of cancer
US7576074B2 (en)	2002-07-15	2009-08-18	Rice Kenneth D	Receptor-type kinase modulators and methods of use
GB0225579D0 (en) *	2002-11-02	2002-12-11	Astrazeneca Ab	Chemical compounds
AU2003278383B2 (en)	2002-11-04	2007-06-14	Astrazeneca Ab	Quinazoline derivatives as Src tyrosine kinase inhibitors
CN100354278C (zh) *	2002-11-04	2007-12-12	阿斯利康(瑞典)有限公司	作为src酪氨酸激酶抑制剂的喹唑啉衍生物
CA2529611C (en)	2002-12-20	2009-12-15	Pfizer Products Inc.	Pyrimidine derivatives for the treatment of abnormal cell growth
US7109337B2 (en)	2002-12-20	2006-09-19	Pfizer Inc	Pyrimidine derivatives for the treatment of abnormal cell growth
GB0307333D0 (en) *	2003-03-29	2003-05-07	Astrazeneca Ab	Therapeutic agent
GB0310401D0 (en) *	2003-05-07	2003-06-11	Astrazeneca Ab	Therapeutic agent
GB0317665D0 (en)	2003-07-29	2003-09-03	Astrazeneca Ab	Qinazoline derivatives
ATE395346T1 (de)	2003-09-16	2008-05-15	Astrazeneca Ab	Chinazolinderivate als tyrosinkinaseinhibitoren
EP2210607B1 (en)	2003-09-26	2011-08-17	Exelixis Inc.	N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer
DE602005010824D1 (de)	2004-02-03	2008-12-18	Astrazeneca Ab	Chinazolinderivate
MXPA06011658A (es)	2004-05-14	2006-12-14	Pfizer Prod Inc	Derivados de pirimidina para el tratamiento del crecimiento celular anormal.
JP2007537238A (ja)	2004-05-14	2007-12-20	ファイザー・プロダクツ・インク	異常細胞増殖の治療のためのピリミジン誘導体
JP2007537230A (ja)	2004-05-14	2007-12-20	ファイザー・プロダクツ・インク	異常細胞増殖の処置用のピリミジン誘導体
JP2008515986A (ja) *	2004-10-13	2008-05-15	ワイス	Ｎ−ベンゼンスルホニル置換アニリノ−ピリミジン類似物
GB0427697D0 (en)	2004-12-17	2005-01-19	Astrazeneca Ab	Chemical process
CN101243030B (zh) *	2005-08-17	2012-02-01	宇部兴产株式会社	4-卤代邻苯二酚化合物的制备方法
JP2009542778A (ja) *	2006-07-13	2009-12-03	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	Ｍｔｋｉキナゾリン誘導体
EP1921070A1 (de)	2006-11-10	2008-05-14	Boehringer Ingelheim Pharma GmbH & Co. KG	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
WO2008076883A2 (en)	2006-12-15	2008-06-26	Abraxis Bioscience, Inc.	Triazine derivatives and their therapeutical applications
AU2008212999A1 (en)	2007-02-06	2008-08-14	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof
TWI377944B (en) *	2007-06-05	2012-12-01	Hanmi Holdings Co Ltd	Novel amide derivative for inhibiting the growth of cancer cells
US8497369B2 (en)	2008-02-07	2013-07-30	Boehringer Ingelheim International Gmbh	Spirocyclic heterocycles medicaments containing said compounds, use thereof and method for their production
JP5739802B2 (ja)	2008-05-13	2015-06-24	アストラゼネカアクチボラグ	４−（３−クロロ−２−フルオロアニリノ）−７−メトキシ−６−｛［１−（ｎ−メチルカルバモイルメチル）ピペリジン−４−イル］オキシ｝キナゾリンのフマル酸塩
EP2313397B1 (de)	2008-08-08	2016-04-20	Boehringer Ingelheim International GmbH	Cyclohexyloxy-substituierte heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
US20100069340A1 (en) *	2008-09-11	2010-03-18	Wyeth	Pharmaceutical compositions of an src kinase inhibitor and an aromatase inhibitor
MX2011003373A (es) *	2008-09-29	2011-06-09	Sirtris Pharmaceuticals Inc	Quinazolinona, quinolona y analogos relacionados como moduladores de sirtuina.
NZ779754A (en)	2009-01-16	2023-04-28	Exelixis Inc	Malate salt of n-(4-{ [6,7-bis(methyloxy)quinolin-4-yl] oxy} phenyl)-n’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
EP2440053A4 (en)	2009-06-09	2012-10-31	California Capital Equity Llc	BENZYL SUBSTITUTED TRIAZINE DERIVATIVES AND THERAPEUTIC APPLICATIONS THEREOF
JP5785940B2 (ja)	2009-06-09	2015-09-30	アブラクシスバイオサイエンス，エルエルシー	トリアジン誘導体類及びそれらの治療応用
UA108618C2 (uk)	2009-08-07	2015-05-25		Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку
CN102617463A (zh) *	2012-02-28	2012-08-01	苏州卡耐博生物技术有限公司	喹啉衍生物和喹唑啉衍生物及它们的制备方法
CN108064274A (zh)	2014-07-30	2018-05-22	耶达研究及发展有限公司	用于培养多能干细胞的培养基
HRP20240793T1 (hr)	2018-04-18	2024-09-13	Constellation Pharmaceuticals, Inc.	Modulatori enzima koji modificiraju metil, njihovi pripravci i upotreba
EP3797108B1 (en)	2018-05-21	2022-07-20	Constellation Pharmaceuticals, Inc.	Modulators of methyl modifying enzymes, compositions and uses thereof
EP3914698B1 (en)	2019-01-23	2024-12-11	Yeda Research and Development Co. Ltd	Culture media for pluripotent stem cells
LT4003532T (lt)	2019-07-24	2024-11-11	Constellation Pharmaceuticals, Inc.	7-chlor-2- (4-(3-metoksiazetidin-1-il)cikloheksil)-2,4-dimetil-n-((6-metil-4-(metiltio)-2-okso-1,2-dihidropiridin-3-il)metil)benzo[d][1,3]dioksol-5-karboksamido kristalinės formos
CN116120273B (zh) *	2023-02-15	2025-05-13	爱斯特（成都）生物制药股份有限公司	一种制备5-溴苯并[d][1,3]二氧-4-胺的方法
WO2025009910A1 (ko) *	2023-07-04	2025-01-09	부산대학교 산학협력단	퀴나졸린 유도체 화합물 및 이의 용도

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5411963A (en)	1988-01-29	1995-05-02	Dowelanco	Quinazoline derivatives
IL89029A (en)	1988-01-29	1993-01-31	Lilly Co Eli	Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them
US5710158A (en)	1991-05-10	1998-01-20	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
US5721237A (en)	1991-05-10	1998-02-24	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
SG64322A1 (en)	1991-05-10	1999-04-27	Rhone Poulenc Rorer Int	Bis mono and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
NZ243082A (en)	1991-06-28	1995-02-24	Ici Plc	4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
RU2043352C1 (ru) *	1991-07-01	1995-09-10	Пермский фармацевтический институт	2-пропил-3- (5-нитрофурфулиден)амино- 4(3н)-хиназолинон, проявляющий противостафилококковую и анальгетическую активность
PT100905A (pt) *	1991-09-30	1994-02-28	Eisai Co Ltd	Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
GB9300059D0 (en)	1992-01-20	1993-03-03	Zeneca Ltd	Quinazoline derivatives
GB9323290D0 (en)	1992-12-10	1994-01-05	Zeneca Ltd	Quinazoline derivatives
RU2118322C1 (ru) *	1993-07-05	1998-08-27	Дюфар Интернэшнл Рисерч Б.В.	2,3-дигидро-1,4-бензодиокси-5-ил-пиперазиновые производные или их соли
RU2137762C1 (ru)	1994-02-23	1999-09-20	Пфайзер Инк.	4-гетероциклил-замещенные производные хиназолина, фармацевтическая композиция
WO1995024190A2 (en) *	1994-03-07	1995-09-14	Sugen, Inc.	Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
GB9510757D0 (en)	1994-09-19	1995-07-19	Wellcome Found	Therapeuticaly active compounds
GB9419318D0 (en) *	1994-09-24	1994-11-09	Pfizer Ltd	Therapeutic agents
TW321649B (no)	1994-11-12	1997-12-01	Zeneca Ltd
GB2295387A (en)	1994-11-23	1996-05-29	Glaxo Inc	Quinazoline antagonists of alpha 1c adrenergic receptors
GB9424233D0 (en)	1994-11-30	1995-01-18	Zeneca Ltd	Quinazoline derivatives
DE69536015D1 (de)	1995-03-30	2009-12-10	Pfizer Prod Inc	Chinazolinone Derivate
US6046206A (en)	1995-06-07	2000-04-04	Cell Pathways, Inc.	Method of treating a patient having a precancerous lesions with amide quinazoline derivatives
GB9514265D0 (en)	1995-07-13	1995-09-13	Wellcome Found	Hetrocyclic compounds
GB9624482D0 (en)	1995-12-18	1997-01-15	Zeneca Phaema S A	Chemical compounds
US5760041A (en)	1996-02-05	1998-06-02	American Cyanamid Company	4-aminoquinazoline EGFR Inhibitors
DE69720965T2 (de)	1996-02-13	2004-02-05	Astrazeneca Ab	Chinazolinderivate und deren verwendung als vegf hemmer
GB9603097D0 (en)	1996-02-14	1996-04-10	Zeneca Ltd	Quinazoline compounds
GB9603095D0 (en)	1996-02-14	1996-04-10	Zeneca Ltd	Quinazoline derivatives
GB9607729D0 (en) *	1996-04-13	1996-06-19	Zeneca Ltd	Quinazoline derivatives
AR007857A1 (es)	1996-07-13	1999-11-24	Glaxo Group Ltd	Compuestos heterociclicos fusionados como inhibidores de proteina tirosina quinasa, sus metodos de preparacion, intermediarios uso en medicina ycomposiciones farmaceuticas que los contienen.
GB9718972D0 (en)	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
AUPO257096A0 (en) *	1996-09-25	1996-10-17	Bhp Steel (Jla) Pty Limited	Production of striped coatings on strip
EP0837063A1 (en)	1996-10-17	1998-04-22	Pfizer Inc.	4-Aminoquinazoline derivatives
AR012634A1 (es)	1997-05-02	2000-11-08	Sugen Inc	Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
TW436485B (en)	1997-08-01	2001-05-28	American Cyanamid Co	Substituted quinazoline derivatives
IL139641A0 (en)	1998-05-28	2002-02-10	Parker Hughes Inst	Quinazolines for treating brain tumor
WO2000000202A1 (en)	1998-06-30	2000-01-06	Parker Hughes Institute	Method for inhibiting c-jun expression using jak-3 inhibitors
KR20010089171A (ko)	1998-08-21	2001-09-29	추후제출	퀴나졸린 유도체
US7262201B1 (en)	1998-10-08	2007-08-28	Astrazeneca Ab	Quinazoline derivatives
IL132366A0 (en) *	1998-10-15	2001-03-19	Cell Pathways Inc	Methods for identifying compounds for inhibition of neoplastic lesions and pharmaceutical compositions containing such compounds
PT1154774E (pt) *	1999-02-10	2005-10-31	Astrazeneca Ab	Derivados de quinazolina como inibidores de angiogenese
CA2361174C (en)	1999-02-27	2009-10-27	Boehringer Ingelheim Pharma Kg	4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
US6080747A (en)	1999-03-05	2000-06-27	Hughes Institute	JAK-3 inhibitors for treating allergic disorders
DE19911509A1 (de)	1999-03-15	2000-09-21	Boehringer Ingelheim Pharma	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
CA2384282A1 (en)	1999-09-21	2001-03-29	Astrazeneca Ab	Quinazoline compounds and pharmaceutical compositions containing them
GB9922173D0 (en)	1999-09-21	1999-11-17	Zeneca Ltd	Chemical compounds
CA2384291A1 (en)	1999-09-21	2001-03-29	Astrazeneca Ab	Quinazoline derivatives and their use as pharmaceuticals
ES2267748T3 (es)	2000-04-07	2007-03-16	Astrazeneca Ab	Compuestos de quinazolina.
UA73993C2 (uk)	2000-06-06	2005-10-17	Астразенека Аб	Хіназолінові похідні для лікування пухлин та фармацевтична композиція
JP2004511479A (ja)	2000-10-13	2004-04-15	アストラゼネカ　アクチボラグ	キナゾリン誘導体
AU2001292137A1 (en)	2000-10-13	2002-04-22	Astrazeneca Ab	Quinazoline derivatives
AU2002212436A1 (en)	2000-10-25	2002-05-06	Astrazeneca Ab	Quinazoline derivatives
JP4307843B2 (ja)	2001-04-19	2009-08-05	アストラゼネカアクチボラグ	キナゾリン誘導体
WO2003008409A1 (en)	2001-07-16	2003-01-30	Astrazeneca Ab	Quinoline derivatives and their use as tyrosine kinase inhibitors

2001
- 2001-08-15 WO PCT/GB2001/003649 patent/WO2002016352A1/en not_active Ceased
- 2001-08-15 AU AU7860901A patent/AU7860901A/xx active Pending
- 2001-08-15 CN CNB018177409A patent/CN100347169C/zh not_active Expired - Fee Related
- 2001-08-15 EP EP01956688A patent/EP1313727A1/en not_active Withdrawn
- 2001-08-15 EE EEP200300071A patent/EE05387B1/xx not_active IP Right Cessation
- 2001-08-15 NZ NZ523702A patent/NZ523702A/en unknown
- 2001-08-15 CZ CZ2003486A patent/CZ2003486A3/cs unknown
- 2001-08-15 BR BR0113358-6A patent/BR0113358A/pt not_active Application Discontinuation
- 2001-08-15 IL IL15413101A patent/IL154131A0/xx unknown
- 2001-08-15 CA CA002419301A patent/CA2419301C/en not_active Expired - Fee Related
- 2001-08-15 KR KR1020087005460A patent/KR20080027400A/ko not_active Withdrawn
- 2001-08-15 KR KR1020037002441A patent/KR100821446B1/ko not_active Expired - Fee Related
- 2001-08-15 MX MXPA03001332A patent/MXPA03001332A/es active IP Right Grant
- 2001-08-15 PL PL360591A patent/PL202812B1/pl not_active IP Right Cessation
- 2001-08-15 RU RU2003107683/04A patent/RU2267489C2/ru not_active IP Right Cessation
- 2001-08-15 US US10/344,678 patent/US7115615B2/en not_active Expired - Fee Related
- 2001-08-15 SK SK214-2003A patent/SK2142003A3/sk not_active Application Discontinuation
- 2001-08-15 JP JP2002521453A patent/JP2004506732A/ja not_active Ceased
- 2001-08-15 AU AU2001278609A patent/AU2001278609B2/en not_active Ceased
- 2001-08-20 MY MYPI20013907A patent/MY129809A/en unknown
- 2001-08-21 AR ARP010103972A patent/AR033560A1/es not_active Application Discontinuation
- 2001-09-14 TW TW90122895A patent/TWI280960B/zh not_active IP Right Cessation
2003
- 2003-01-26 IL IL154131A patent/IL154131A/en not_active IP Right Cessation
- 2003-02-20 NO NO20030795A patent/NO326515B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
NO326515B1 (no)	2008-12-22
US20040034046A1 (en)	2004-02-19
JP2004506732A (ja)	2004-03-04
PL360591A1 (en)	2004-09-06
PL202812B1 (pl)	2009-07-31
AU7860901A (en)	2002-03-04
AU2001278609B2 (en)	2005-04-14
TWI280960B (en)	2007-05-11
US7115615B2 (en)	2006-10-03
CN1471527A (zh)	2004-01-28
WO2002016352A1 (en)	2002-02-28
AR033560A1 (es)	2003-12-26
MXPA03001332A (es)	2004-07-08
NO20030795D0 (no)	2003-02-20
IL154131A0 (en)	2003-07-31
CZ2003486A3 (cs)	2003-05-14
RU2267489C2 (ru)	2006-01-10
CN100347169C (zh)	2007-11-07
MY129809A (en)	2007-05-31
CA2419301A1 (en)	2002-02-28
BR0113358A (pt)	2003-07-01
KR100821446B1 (ko)	2008-04-10
EE200300071A (et)	2004-12-15
SK2142003A3 (en)	2003-07-01
KR20080027400A (ko)	2008-03-26
CA2419301C (en)	2009-12-08
KR20030022416A (ko)	2003-03-15
IL154131A (en)	2010-04-15
NZ523702A (en)	2004-08-27
EP1313727A1 (en)	2003-05-28
EE05387B1 (et)	2011-02-15

Legal Events

Date	Code	Title	Description
2012-03-26	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO20030795D0 (no)	2003-02-20	Kinazolinderivater
ATE290000T1 (de)	2005-03-15	Muscarinagonisten
ATE252099T1 (de)	2003-11-15	Biarylcarboxamide
DE10136334B8 (de)	2009-11-26	Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser
ATE312098T1 (de)	2005-12-15	Thiazinoxazolidinon
ATA2932001A (de)	2004-11-15	Schneefräse
DE50102988D1 (de)	2004-09-02	Bodenwischer
DE50100710D1 (de)	2003-11-06	Wischblatt
ATE262530T1 (de)	2004-04-15	Indolochinazolinone
NO20030276L (no)	2003-03-18	Fremgangsmåte
NO20035573L (no)	2004-02-16	Kinazolinderivater
AR028336A1 (es)	2003-05-07	4-hidroxi-tetrahidropiridonas fenilsubstituidas
DE10192638T1 (de)	2002-10-31	Bohrstangenladevorrichtung
ATE509008T1 (de)	2011-05-15	Sulfonylguanidine
DE10196064T1 (de)	2003-03-13	Halbleiterfotodektionsgerät
DE50100817D1 (de)	2003-11-27	Kugelgelenk
DE50011511D1 (de)	2005-12-08	Blowby-Heizung
AR027931A1 (es)	2003-04-16	Antitranspirantes
AR028061A1 (es)	2003-04-23	2-enamino-cetonitrilos fenil-substituidos
DE50007634D1 (de)	2004-10-07	Kardioplegieballonkatheter
ATE476423T1 (de)	2010-08-15	Benzoylpyridazine
DE10052925B4 (de)	2005-03-10	Schaukelbett
DE10195909T1 (de)	2003-02-20	Viehfüttervorrichtung
AR027982A1 (es)	2003-04-23	Aril- y heteroarilsulfonatos
DE10195992T1 (de)	2003-02-27	Oberflächenendbearbeitungsbelag